Electron microscopy of therapeutic and diagnostic nanoparticles

治疗和诊断纳米颗粒的电子显微镜

基本信息

项目摘要

We have analyzed bionanoparticles that are designed for labeling cells and then imaging those cells in animal models by in vivo magnetic resonance imaging. These nanocomplexes, comprising three FDA-approved drugs (heparin, protamine and ferumoxytol), can be taken up into human cell lines, and detected when implanted into rodents. The major component of the ferumoxytol component is superparamagetic iron oxide nanoparticle (SPIONP), which provides MRI contrast for diagnostic imaging. We have performed electron tomography and energy-filtered transmission electron microscopy (EFTEM) to determine the distribution of the three constituents within the individual nanocomplexes using element-specific signals. The protamine component was imaged with the nitrogen signal, the heparin component with the sulfur signal, and the surrounding shell of ferumoxytol with the iron signal. Electron tomography was also employed to visualize the three-dimensional organization of the ferumoxytol nanoparticles within the approximately 200-nm diameter nanocomplexes. Our analysis showed that the nanocomplexes contained a homogeneous soft core consisting of approximately a 1:1 mass ratio of protamine and heparin, consistent with a balancing of the positive charge on protamine with the negative charge on heparin. Electron microscopy has enabled us to characterize another SPIONP that is combined with a nano-drug formulation consisting of the anti-cancer drug doxorubicin loaded into a polyethyleneimine-coating on the iron oxide nanoparticles, forming a theranostic nanocomplex. Magnetic nanocrystals like SPIONPs have been developed mainly as MRI contrast agents and as magnetic labels for tracking stem cells. However, with this design, the SPIONPs can function as drug delivery vehicles to reach tumor sites and image those sites through magnetic contrast. We have also used EFTEM to characterize the composition of manganese-block copolymer complexes (MnBCs) containing paramagnetic Mn ions complexed with ionic-nonionic poly(ethylene oxide-b-poly(methacrylate), which have been developed for use as a T1-weighted magnetic resonance image contrast agent. The particles had a uniform distribution of manganese, as evident from the L2,3 core edge intensity, and the presence of a nitrogen K peak suggested that an amide bond was formed after the crosslinking reaction. By encasing Mn ion within this ionized polymer matrix, MRI contrast was found to increased by 250-350 % in comparison with free Mn ion at relative high fields.
我们已经分析了生物纳米颗粒,这些生物纳米颗粒被设计用于标记细胞,然后通过体内磁共振成像在动物模型中对这些细胞进行成像。 这些纳米复合物包含三种FDA批准的药物(肝素,鱼精蛋白和ferumoxytol),可以被人体细胞系吸收,并在植入啮齿动物时被检测到。 ferumoxytol组分的主要成分是超顺磁性氧化铁纳米颗粒(SPIONP),其为诊断成像提供MRI对比。 我们已经进行了电子断层扫描和能量过滤透射电子显微镜(EFTEM),以确定使用元素特异性信号的三种成分在单个纳米复合物内的分布。 鱼精蛋白组分用氮信号成像,肝素组分用硫信号成像,并且ferumoxytol的周围壳用铁信号成像。 电子断层扫描也被用来可视化的三维组织的ferumoxytol纳米颗粒内的约200 nm直径的纳米复合物。我们的分析表明,纳米复合物含有由大约1:1质量比的鱼精蛋白和肝素组成的均匀软核,这与鱼精蛋白上的正电荷与肝素上的负电荷的平衡一致。 电子显微镜使我们能够表征另一种SPIONP,该SPIONP与纳米药物制剂相结合,该纳米药物制剂由抗癌药物阿霉素加载到氧化铁纳米颗粒上的聚乙烯亚胺涂层中,形成治疗诊断纳米复合物。 磁性纳米晶体如SPIONP主要被开发为MRI造影剂和用于跟踪干细胞的磁性标签。 然而,通过这种设计,SPIONP可以作为药物递送载体到达肿瘤部位,并通过磁对比对这些部位进行成像。 我们还使用EFTEM来表征锰嵌段共聚物复合物(MnBC)的组成,该复合物含有与离子-非离子聚(环氧乙烷-b-聚(甲基丙烯酸酯))复合的顺磁性Mn离子,其已被开发用作T1加权磁共振图像造影剂。 从L2,3核边缘强度可以看出,颗粒具有均匀的锰分布,并且氮K峰的存在表明在交联反应后形成了酰胺键。 通过将Mn离子包封在该电离的聚合物基质内,发现MRI对比度在相对高的场下与游离Mn离子相比增加了250- 350%。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Richard Leapman其他文献

Richard Leapman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Richard Leapman', 18)}}的其他基金

Structure Of Beta Amyloid Fibrils
β淀粉样原纤维的结构
  • 批准号:
    7967868
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Platinum Accumulation in Pigmented Granules of Cisplatin-Treated Melanoma Cells
顺铂处理的黑色素瘤细胞色素颗粒中铂的积累
  • 批准号:
    7967892
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Development of Conjugated Gold Clusters for Studies on Cellular Internalization
用于细胞内化研究的共轭金簇的开发
  • 批准号:
    8933888
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Mass Mapping of Macromolecular Assemblies
大分子组装体的质量作图
  • 批准号:
    8743765
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Energy-Filtered Electron Tomography
能量过滤电子断层扫描
  • 批准号:
    8743771
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Ultrastructure of a Carbon Nanotube-based Delivery System for Cancer Therapy
用于癌症治疗的碳纳米管输送系统的超微结构
  • 批准号:
    8340620
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Intramural Training of NIH Biomedical Imaging and Bioengineering Researchers
NIH 生物医学成像和生物工程研究人员的校内培训
  • 批准号:
    8340644
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Three-Dimensional Cell and Tissue Reconstruction by Serial Block Face SEM
通过串行块面 SEM 进行三维细胞和组织重建
  • 批准号:
    9361491
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Energy-Filtered Electron Microscopy and Electron Spectroscopic Imaging
能量过滤电子显微镜和电子光谱成像
  • 批准号:
    10011332
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:
Mass Mapping of Macromolecular Assemblies
大分子组装体的质量作图
  • 批准号:
    7593811
  • 财政年份:
  • 资助金额:
    $ 18.42万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 18.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了